NCT05930080

Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial

Multi-center, Randomized, Double Blinded, Active-controlled Phase III Clinical Trial to Assess the Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 278 (actual)
• Sponsor: SK Chemicals Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Multi-center, Randomized, Double Blinded, Active-controlled Phase III Clinical Trial to Assess the Efficacy and Safety of SKCPT in Patients with knee Osteoarthritis

Conditions

• Osteoarthritis, Knee

Interventions

Type	Name	Description
DRUG	SKCPT	the randomly assigned subjects took the study drug for 12 weeks
DRUG	Celebrex	the randomly assigned subjects took the study drug for 12 weeks

Timeline

• Start date: 2021-01-28
• Primary completion: 2022-05-19
• Completion: 2022-09-30
• First posted: 2023-07-05
• Last updated: 2023-07-06

Locations

1 site across 1 country: South Korea